DE3850654D1 - Immunglobulin-e-kompetitor. - Google Patents

Immunglobulin-e-kompetitor.

Info

Publication number
DE3850654D1
DE3850654D1 DE3850654T DE3850654T DE3850654D1 DE 3850654 D1 DE3850654 D1 DE 3850654D1 DE 3850654 T DE3850654 T DE 3850654T DE 3850654 T DE3850654 T DE 3850654T DE 3850654 D1 DE3850654 D1 DE 3850654D1
Authority
DE
Germany
Prior art keywords
polypeptide
sequence
ige
amino acids
competitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3850654T
Other languages
English (en)
Other versions
DE3850654T2 (de
Inventor
Hannah Gould
Birgit Helm
Philip Marsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3I Research Exploitation Ltd
Original Assignee
3I Research Exploitation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3I Research Exploitation Ltd filed Critical 3I Research Exploitation Ltd
Application granted granted Critical
Publication of DE3850654D1 publication Critical patent/DE3850654D1/de
Publication of DE3850654T2 publication Critical patent/DE3850654T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE3850654T 1987-11-19 1988-11-18 Immunglobulin-e-kompetitor. Expired - Fee Related DE3850654T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878727045A GB8727045D0 (en) 1987-11-19 1987-11-19 Immunoglobulin e competitor
PCT/GB1988/001018 WO1989004834A1 (en) 1987-11-19 1988-11-18 Immunoglobulin e competitor

Publications (2)

Publication Number Publication Date
DE3850654D1 true DE3850654D1 (de) 1994-08-18
DE3850654T2 DE3850654T2 (de) 1994-12-15

Family

ID=10627189

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850654T Expired - Fee Related DE3850654T2 (de) 1987-11-19 1988-11-18 Immunglobulin-e-kompetitor.

Country Status (6)

Country Link
EP (1) EP0341290B1 (de)
JP (1) JP2721256B2 (de)
AT (1) ATE108458T1 (de)
DE (1) DE3850654T2 (de)
GB (1) GB8727045D0 (de)
WO (1) WO1989004834A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
US6329509B1 (en) 1991-08-14 2001-12-11 Genentech, Inc. Anti-IgE antibodies
ES2193136T3 (es) * 1991-08-14 2003-11-01 Genentech Inc Variantes de inmunoglubina para receptores especificos de fc epsilon.
US5994514A (en) * 1991-08-14 1999-11-30 Genentech, Inc. Immunoglobulin variants
US6685939B2 (en) 1991-08-14 2004-02-03 Genentech, Inc. Method of preventing the onset of allergic disorders
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
JP3507852B2 (ja) * 1993-12-10 2004-03-15 ジェネンテク，インコーポレイテッド アレルギー診断法および抗アレルギー性治療剤のスクリーニング法
FR2715304B1 (fr) * 1994-01-26 1996-04-26 Merieux Serums Vaccins Pasteur Vaccin anti-allergique.
US6037453A (en) * 1995-03-15 2000-03-14 Genentech, Inc. Immunoglobulin variants
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
IL125590A (en) 1996-03-01 2001-08-26 Novartis Ag Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
WO1998024808A2 (en) * 1996-12-06 1998-06-11 THE UNITED STATES OF AMERICA represented by THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES, THE NATIONAL INSTITUTES OF HEALTH INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
WO2001051507A1 (fr) * 2000-01-14 2001-07-19 Daiichi Pharmaceutical Co., Ltd. Nouveau peptide et procede de criblage utilisant ledit peptide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944399A (ja) * 1982-09-07 1984-03-12 Takeda Chem Ind Ltd 新規ｄｎａ
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
PT85364B (pt) * 1986-07-22 1990-04-30 Ciba Geigy Ag Metodo para a producao de polipeptideos relacionados com factores de ligacao
EP0257114A1 (de) * 1986-08-21 1988-03-02 Kishimoto, Tadamitsu, Prof. Menschlicher Fc-Epsilon-Rezeptor von niedriger Affinität, dessen Isolierung und Reinigung
JPS63225397A (ja) * 1986-10-03 1988-09-20 Dainippon Pharmaceut Co Ltd 抗アレルギー作用を有する新規ペプチド
EP0269455A3 (de) * 1986-11-28 1989-09-06 Takeda Chemical Industries, Ltd. Hochgereinigtes Fusionsprotein, das ein menschliches IgE Fc-Fragment enthält, sowie dessen Herstellung

Also Published As

Publication number Publication date
DE3850654T2 (de) 1994-12-15
JP2721256B2 (ja) 1998-03-04
WO1989004834A1 (en) 1989-06-01
GB8727045D0 (en) 1987-12-23
EP0341290B1 (de) 1994-07-13
ATE108458T1 (de) 1994-07-15
JPH02502191A (ja) 1990-07-19
EP0341290A1 (de) 1989-11-15

Similar Documents

Publication Publication Date Title
DE3850654D1 (de) Immunglobulin-e-kompetitor.
ATE134647T1 (de) Osteogene vorrichtungen
NO974812L (no) Nytt protein og fremgangsmåte for fremstilling av dette
ES2120964T3 (es) Peptidos osteogenicos.
HU9200548D0 (en) Improved activity process of recombined proteins
KR900702027A (ko) 사람 / 소의 염기성 섬유 아세포 성장 인자의 유도체
ES2017122A6 (es) Procedimiento de preparacion de proteina de ligado de heparina.
WO1988000204A3 (en) Polypeptide competitor for immunoglobulin e
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
TW198040B (de)
EP0276778A3 (de) Expression mit hochstufiger Verstärkung von löslichem reifem IL-1beta und Derivate mit geänderter biologischer Aktivität
AU6860294A (en) New chondrocyte proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee